Browsing: Basic > Immunology
Researchers have identified a subpopulation of T cells as key cytokine producers in addition to proposing a novel mechanism of immunosuppression following superantigen exposure.
Improved therapeutic strategies are in urgent need for better control and eradication of tuberculosis. In this editorial, the authors evaluate interleukin-37 as a new molecular target for the therapy of tuberculosis.
Research presented at ASM Microbe has reported a Zika vaccine based on the NS1 protein can induce protective immunity in mouse models after a single dose.
Researchers have discovered that compounds altering transmembrane potential in Xenopus laevis may improve resistance to E. coli infection.
Helen McShane discusses her work leading the TB vaccine research program at Oxford University, and shares her thoughts on the challenges facing vaccine development and eradication of this disease.
Study discovers that high levels of maternal microchimerism may directly affect the offspring’s immune system even after birth.
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis based on the realtionship with Epstein–Barr virus.
Researchers have utilized CRISPR/Cas9 technology on human induced pluripotent stem cells to identify genes involved in fighting off Chlamydia trachomatis infections.
Given the ability of the microbiota to instruct the immune system and control the inflammatory response, the authors discuss the potential of targeting the microbiota to improve the immune recovery and dampen inflammation during HIV infection.